REGIS HEALTHCARE LIMITED (REG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

REG - REGIS HEALTHCARE LIMITED

FNArena Sector : Aged Care & Seniors
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 1.42
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.15

22 Jul
2024

-0.150

OPEN

$4.24

-3.49%

HIGH

$4.25

479,559

LOW

$4.14

TARGET
$4.875 17.5% upside
Franking for last dividend paid out: 50%
OTHER COMPANIES IN THE SAME SECTOR
EGH . INA . LIC . OCA .
FNARENA'S MARKET CONSENSUS FORECASTS
REG: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx - 9.5 11.8 xxx
DPS (cps) xxx 9.5 12.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx 62.3% 26.6% xxx
PE Ratio xxx N/A 35.3 xxx
Dividend Yield xxx N/A 2.9% xxx
Div Pay Ratio(%) xxx N/A 102.1% xxx

Dividend yield today if purchased 3 years ago: 4.96%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.20

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 14/03 - ex-div 6.28c (franking 50%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-9.5
DPS All xxxxxxxxxxxxxxx9.5
Sales/Revenue xxxxxxxxxxxxxxx771.5 M
Book Value Per Share xxxxxxxxxxxxxxx12.8
Net Operating Cash Flow xxxxxxxxxxxxxxx105.2 M
Net Profit Margin xxxxxxxxxxxxxxx-3.69 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-48.47 %
Return on Invested Capital xxxxxxxxxxxxxxx-19.72 %
Return on Assets xxxxxxxxxxxxxxx-1.64 %
Return on Equity xxxxxxxxxxxxxxx-48.47 %
Return on Total Capital xxxxxxxxxxxxxxx-50.61 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx40.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx70 M
Total Debt xxxxxxxxxxxxxxx71 M
Goodwill - Gross xxxxxxxxxxxxxxx262 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx61 M
Price To Book Value xxxxxxxxxxxxxxx17.40

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx51.4 M
Capex % of Sales xxxxxxxxxxxxxxx6.67 %
Cost of Goods Sold xxxxxxxxxxxxxxx775 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx73 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx117 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

13/03/2024

1

Buy

$4.25

2.41%

The Aged Care Taskforce's Final Report is advocating a user pays regime for residential care and Ord Minnett believes this will pan out as a positive for the sector, including for Regis Healthcare.

The broker continues to see risks to the upside for Regis Healthcare, with occupancy levels improving, an ongoing expansion of funding streams, plus an M&A pipeline.

Target rises to $4.25 from $3.90, Buy retained.

FORECAST
Ord Minnett forecasts a full year FY24 dividend of 12.90 cents and EPS of 12.50 cents.
Ord Minnett forecasts a full year FY25 dividend of 15.30 cents and EPS of 15.30 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

07/03/2024

2

Overweight

$3.64

-12.29%

Regis Healthcare delivered an operating result in the first half that was ahead of Jarden''s estimates, with higher government revenue the main driver. Net profit was lower than expected but this was largely because of one-off acquisition costs.

The broker expects momentum to continue into the second half with spot occupancy increasing to 94.5%. Further improvement to 95.8% is expected by FY26. The staff shortages are improving. Overweight retained. Target is raised to $3.64 from $3.35.

FORECAST
Jarden forecasts a full year FY24 dividend of 8.30 cents and EPS of 11.20 cents.
Jarden forecasts a full year FY25 dividend of 4.00 cents and EPS of 14.90 cents.

REG STOCK CHART